Immutep IMMP
NASDAQ IMMP
$0.39 0.00 (-1.28%)
At close: Aug 21, 2026 · 4:00 PM EDT

Immutep (IMMP) Profit After Tax (2011 - 2024)

Immutep's (IMMP) quarterly Profit After Tax came in at -$2.6 million in Q4 2024, down 113.59% YoY from $19.4 million in Q1 2024, and up 90.62% on a QoQ basis from -$28.2 million in Q2 2024.

Immutep (IMMP) Profit After Tax (2011 - 2024) Analysis & Trends

Immutep (IMMP) has 14 years of Profit After Tax data on file, last reported at -$2.6 million in Q4 2024.

  • Quarterly Profit After Tax fell 113.59% year-over-year to -$2.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$58.7 million (down 103.39% YoY) and the FY2025 annual result came in at -$39.3 million, down 39.76% from the prior year.
  • Profit After Tax rose to -$2.6 million in Q4 2024, from -$28.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$422669.6 in Q4 2021 to a low of -$28.2 million in Q2 2024.
  • A 5-year average of -$9.8 million and a median of -$2.6 million in 2024 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2020 — Profit After Tax soared 31.3% — and 2023, when it tumbled 131.58%.
  • Tracing IMMP's Profit After Tax over 5 years: stood at -$8.8 million in 2020, then soared by 95.21% to -$422669.6 in 2021, then fell by 26.34% to -$534020.1 in 2022, then slumped by 131.58% to -$1.2 million in 2023, then slumped by 113.59% to -$2.6 million in 2024.
  • The last three Profit After Tax figures came in at -$2.6 million (Q4 2024), -$28.2 million (Q2 2024), and -$1.2 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Immutep 56.46 Mn -8.63 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.64 Mn
Jun 30, 2024 -28.15 Mn
Dec 31, 2023 -1.24 Mn
Jun 30, 2023 -26.67 Mn
Dec 31, 2022 -534,020.09
Dec 31, 2021 -422,669.57
Jun 30, 2020 -8.83 Mn
Dec 31, 2019 -670,750.76
Jun 30, 2019 -12.85 Mn
Dec 31, 2018 -944,731.60
Jun 30, 2017 -7.04 Mn
Mar 31, 2017 -1.80 Mn
Dec 31, 2016 -461,772.75
Jun 30, 2016 -46.31 Mn
Mar 31, 2016 -1.99 Mn
Jun 30, 2015 -25.00 Mn
Jun 30, 2014 -12.44 Mn
Jun 30, 2013 -15.13 Mn
Dec 31, 2012 69,562.20
Jun 30, 2012 -20.15 Mn